BioDrugs (original) (raw)
From Wikipedia, the free encyclopedia
Academic journal
BioDrugs
| Discipline | Drug therapy, pharmacology |
|---|---|
| Language | English |
| Edited by | Kathy Fraser |
| Publication details | |
| History | 1994-present |
| Publisher | Adis International (Springer Nature) (New Zealand) |
| Frequency | Bimonthly |
| Open access | Hybrid |
| Impact factor | 5.807 (2020) |
Standard abbreviationsISO 4 (alt) · Bluebook (alt)NLM (alt) · MathSciNet (alt  ) |
|
| ISO 4 | BioDrugs |
| IndexingCODEN (alt · alt2) · JSTOR (alt) · LCCN (alt)MIAR · NLM (alt) · Scopus | |
| CODEN | BIDRF4 |
| ISSN | 1173-8804 (print)1179-190X (web) |
| Links | |
| Journal homepage Online archive |
BioDrugs is a peer-reviewed pharmacology journal. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. It has a 2023 impact factor of 5.4.[1] It is published by Adis International (SpringerNature).